This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Scientist in laboratory

    Alternative complement pathway inhibition with iptacopan in IgA nephropathy

  • Pills being tipped into a hand

    Iptacopan in IgA nephropathy

  • Patient in a consultation

    PARAGON-HF: Kidney function and cardiovascular outcomes with sacubitril/valsartan

  • Heart concept image

    BARACK-D: low-dose spironolactone and cardiovascular outcomes in moderate CKD

  • Rack of blood sample tubes

    Do we fully understand the risk factors associated with venous thromboembolism in nephrotic syndrome?

  • Risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels

  • Effects of heart failure therapies on standardised kidney outcomes

  • Use and safety of finerenone in a routine setting: first interim results from FINE-REAL

  • Sick man in hospital bed

    Unravelling the sex differences and decline in kidney health after 73 years of age

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe